World Gastroenterology Organisation. Acute diarrhea in adults and children: a global perspective. February 2012. http://www.worldgastroenterology.org/ (last accessed 12 March 2017).
1. DuPont HL. Systematic review: the epidemiology and clinical features of travellers' diarrhoea. Aliment Pharmacol Ther. 2009;30:187-196.
2. DuPont H, Ericsson CD. Prevention and treatment of traveler's diarrhea. N Engl J Med. 1993;328:1821-1827.
3. Diemert DJ. Prevention and treatment of traveler's diarrhea. Clin Microbiol Rev. 2006;19:583-594.
4. DuPont HL. Travellers' diarrhoea: contemporary approaches to therapy and prevention. Drugs. 2006;66:303-314.
5. U.S. Food and Drug Administration. Bad bug book: handbook of foodborne pathogenic microorganisms and natural toxins. Second edition. 2012. http://www.fda.gov/ (last accessed 12 March 2017).
6. Bacaner N, Stauffer B, Boulware D, et al. Travel medicine considerations for North American immigrants visiting friends and relatives. JAMA. 2004;291:2856-2864.
7. Martinez-Sandoval F, Ericsson CD, Jiang ZD, et al. Prevention of travelers' diarrhea with rifaximin in US travelers to Mexico. J Travel Med. 2010;17:111-117.
8. Thabane M, Kottachchi DT, Marshall JK. Systematic review and metanalysis: the incidence and prognosis of post-infectious irritable bowel syndrome. Aliment Pharmacol Ther. 2007;26:535-544.
9. van Rheenen P, Van de Vijver E, Fidler V. Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis. BMJ. 2010;341:c3369.
10. von Sonnenburg F, Tornieporth N, Waiyaki P, et al. Risk and aetiology of diarrhoea at various tourist destinations. Lancet. 2000;356:133-134.
11. De Bruyn G, Hahn S, Borwick A. Antibiotic treatment for travellers' diarrhoea. Cochrane Database Syst Rev. 2000;(3):CD002242.
12. Pakyz AL. Rifaximin: a new treatment for traveler's diarrhea. Ann Pharm. 2005;39:284-289.
13. Kantele A, Lääveri T, Mero S, et al. Antimicrobials increase travelers' risk of colonization by extended-spectrum betalactamase-producing Enterobacteriaceae. Clin Infect Dis. 2015;60:837-846.
14. Connor BA, Keystone JS. Antibiotic self-treatment of travelers' diarrhea: helpful or harmful? Clin Infect Dis. 2015;60:847-848.
15. Hu Y, Ren J, Zhan M, et al. Efficacy of rifaximin in prevention of travelers' diarrhea: a meta-analysis of randomized, double-blind, placebo-controlled trials. J Travel Med. 2012;19:352-356.
16. Alajbegovic S, Sanders JW, Atherly DE, et al. Effectiveness of rifaximin and fluoroquinolones in preventing travelers' diarrhea (TD): a systematic review and meta-analysis. Syst Rev. 2012;1:39.
17. World Gastroenterology Organisation. Acute diarrhea in adults and children: a global perspective. February 2012. http://www.worldgastroenterology.org/ (last accessed 12 March 2017).
18. Pichler HE, Diridl G, Stickler K, et al. Clinical efficacy of ciprofloxacin compared with placebo in bacterial diarrhea. Am J Med. 1987;82:329.
19. Taylor DN, Bourgeois AL, Ericsson CD, et al. A randomized, double-blind, multicenter study of rifaximin compared with placebo and with ciprofloxacin in the treatment of travelers' diarrhea. Am J Trop Med Hyg. 2006;74:1060-1066.
20. Riddle MS, Arnold S, Tribble DR. Effect of adjunctive loperamide in combination with antibiotics on treatment outcomes in traveler's diarrhea: a systematic review and meta-analysis. Clin Infect Dis. 2008;47:1007-1014.
21. Takahashi O, Noguchi Y, Omata F, et al. Probiotics in the prevention of traveler's diarrhea: meta-analysis. J Clin Gastroenterol. 2007;41:336-337.
22. McFarland LV. Meta-analysis of probiotics for the prevention of traveler's diarrhea. Travel Med Infect Dis. 2007;5:97-105.
23. Sazawal S, Hiremath G, Dhingra U, et al. Efficacy of probiotics in the prevention of acute diarrhea: a meta-analysis of masked, randomized, placebo-controlled trials. Lancet Infect Dis. 2006;6:374-382.
24. Conner BA; Centers for Disease Control and Prevention. Health information for international travel: travelers’ diarrhea. 2015. http://www.cdc.gov (last accessed 12 March 2017).
25. Kale-Pradhan P, Jassal H, Wilhelm S. Role of Lactobacillus in the prevention of antibiotic-associated diarrhea: a meta-analysis. Pharmacotherapy. 2010;30:119-126.
26. DuPont HL, Ericsson CD, Johnson PC, et al. Prevention of traveler's diarrhea by the tablet formulation of bismuth subsalicylate. JAMA. 1987;257:1347-1350.
27. Riddle MS, Sanders JW, Putnam SD, et al. Incidence, etiology, and impact of diarrhea among long-term travelers (US military and similar populations): a systematic review. Am J Trop Med Hyg. 2006;74:891-900.
28. Drenaggi D, Cirioni O, Giacometti A, et al. Cyclosporiasis in a traveler returning from South America. J Travel Med. 1998;5:153-155.
29. Pitzinger B. Incidence and clinical features of traveler's diarrhea in infants and children. Pediatr Infect Dis. 1991;10:719-723.
30. Guarino A, Lo Vecchio A, Pirozzi MR. Clinical role of diosmectite in the management of diarrhea. Expert Opin Drug Metab Toxicol. 2009;5:433-440.
使用此内容应接受我们的免责声明。
BMJ临床实践的持续改进离不开您的帮助和反馈。如果您发现任何功能问题和内容错误,或您对BMJ临床实践有任何疑问或建议,请您扫描右侧二维码并根据页面指导填写您的反馈和联系信息*。一旦您的建议在我们核实后被采纳,您将会收到一份小礼品。
如果您有紧急问题需要我们帮助,请您联系我们。
邮箱:bmjchina.support@bmj.com
电话:+86 10 64100686-612
*您的联系信息仅会用于我们与您确认反馈信息和礼品事宜。
BMJ临床实践官方反馈平台